C-reactive protein: ligands, receptors and role in inflammation.

[1]  Thomas Francis,et al.  SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS , 1930, The Journal of experimental medicine.

[2]  G. Thorbecke,et al.  THE LIVER AS THE SITE OF C-REACTIVE PROTEIN FORMATION , 1966, The Journal of experimental medicine.

[3]  M. H. Kaplan,et al.  Specificity of C-Reactive Protein for Choline Phosphate Residues of Pneumococcal C-Polysaccharide , 1971, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[4]  J. Volanakis,et al.  Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin. , 1974, Journal of immunology.

[5]  H. Gewurz,et al.  INTERACTIONS OF C-REACTIVE PROTEIN WITH THE COMPLEMENT SYSTEM , 1974, The Journal of experimental medicine.

[6]  J. Gitlin,et al.  LOCALIZATION OF C-REACTIVE PROTEIN IN SYNOVIUM OF PATIENTS WITH RHEUMATOID ARTHRITIS , 1977, Pediatric Research.

[7]  M. Pepys.  Isolation of serum amyloid P-component (protein SAP) in the mouse. , 1979, Immunology.

[8]  C. Mold,et al.  Brief Definitive Report C-reactive Protein Is Protective against Streptococcus Pneumoniae Infection in Mice* , 2022 .

[9]  J. Volanakis,et al.  C‐REACTIVE PROTEIN BINDING SPECIFICITIES: ARTIFICIAL AND NATURAL PHOSPHOLIPID BILAYERS * , 1982, Annals of the New York Academy of Sciences.

[10]  J. Volanakis,et al.  Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in mice. , 1982, Journal of immunology.

[11]  T. Tanaka,et al.  Binding of C-reactive protein to chromatin and nucleosome core particles. A possible physiological role of C-reactive protein. , 1984, The Journal of biological chemistry.

[12]  A. Steinberg,et al.  C-reactive protein mediates the solubilization of nuclear DNA by complement in vitro , 1985, The Journal of experimental medicine.

[13]  P. V. van Helden,et al.  Functional effects of CRP binding to nuclei. , 1986, Immunology.

[14]  Blood clearance of Streptococcus pneumoniae by C-reactive protein. , 1987, Journal of immunology.

[15]  T. D. Du Clos,et al.  Analysis of the binding of C-reactive protein to histones and chromatin. , 1988, Journal of immunology.

[16]  T. D. Du Clos,et al.  C-reactive protein reacts with the U1 small nuclear ribonucleoprotein. , 1989, Journal of immunology.

[17]  N. Goldman,et al.  cis-acting elements responsible for interleukin-6 inducible C-reactive protein gene expression. , 1990, The Journal of biological chemistry.

[18]  J. Tebo,et al.  Characterization and isolation of a C-reactive protein receptor from the human monocytic cell line U-937. , 1990, Journal of immunology.

[19]  T. Speroff,et al.  Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines. , 1991, Journal of immunology.

[20]  L. Marnell,et al.  C-reactive protein (CRP) binding to the Sm-D protein of snRNPS. Identification of a short polypeptide binding region. , 1993, Molecular immunology.

[21]  H. Tilg,et al.  Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells , 1993, The Journal of experimental medicine.

[22]  C. Mold,et al.  Sublytic complement attack exposes C-reactive protein binding sites on cell membranes. , 1994, Journal of immunology.

[23]  C. Mold,et al.  Decreased autoantibody levels and enhanced survival of (NZB x NZW) F1 mice treated with C-reactive protein. , 1994, Clinical immunology and immunopathology.

[24]  J. Volanakis,et al.  Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice. , 1995, Journal of immunology.

[25]  L. Marnell,et al.  C-reactive protein binds to Fc gamma RI in transfected COS cells. , 1995, Journal of immunology.

[26]  Dongxiao Zhang,et al.  STAT3 Participates in Transcriptional Activation of the C-reactive Protein Gene by Interleukin-6 (*) , 1996, The Journal of Biological Chemistry.

[27]  I. T. Ten Berge,et al.  CRP-mediated activation of complement in vivo: assessment by measuring circulating complement-C-reactive protein complexes. , 1996, Journal of immunology.

[28]  J. Volanakis,et al.  HUMAN C-REACTIVE PROTEIN , 1997 .

[29]  D. Xia,et al.  Transgenic mice expressing rabbit C-reactive protein are resistant to endotoxemia. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Q. Zen,et al.  Effect of human C-reactive protein on chemokine and chemotactic factor-induced neutrophil chemotaxis and signaling. , 1998, Journal of immunology.

[31]  J. Weiser,et al.  Adaptation of Haemophilus influenzae to acquired and innate humoral immunity based on phase variation of lipopolysaccharide , 1998, Molecular microbiology.

[32]  D. Musher,et al.  Phosphorylcholine on the Lipopolysaccharide of Haemophilus influenzae Contributes to Persistence in the Respiratory Tract and Sensitivity to Serum Killing Mediated by C-reactive Protein , 1998, The Journal of experimental medicine.

[33]  C. Mold,et al.  Regulation of complement activation by C-reactive protein. , 1999, Immunopharmacology.

[34]  S. Wood,et al.  The physiological structure of human C-reactive protein and its complex with phosphocholine. , 1999, Structure.

[35]  D. Bharadwaj,et al.  The major receptor for c-reactive protein on leukocytes FcyII , 1999 .

[36]  N. Brot,et al.  C-Reactive Protein Binds to Apoptotic Cells, Protects the Cells from Assembly of the Terminal Complement Components, and Sustains an Antiinflammatory Innate Immune Response , 2000, The Journal of experimental medicine.

[37]  J. Volanakis,et al.  Human C-Reactive Protein Is Protective against Fatal Salmonella enterica Serovar Typhimurium Infection in Transgenic Mice , 2000, Infection and Immunity.

[38]  C-reactive protein binding to FcgRIIa on human monocytes , 2000 .

[39]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[40]  C. Mold,et al.  Serum Amyloid P Component Binds to Fcγ Receptors and Opsonizes Particles for Phagocytosis1 , 2001, The Journal of Immunology.

[41]  C. Mold,et al.  Serum Amyloid P Component and C-Reactive Protein Mediate Phagocytosis Through Murine FcγRs1 , 2001, The Journal of Immunology.

[42]  J. Volanakis,et al.  Topology and Structure of the C1q-Binding Site on C-Reactive Protein1 , 2001, The Journal of Immunology.

[43]  C. Mold,et al.  C-Reactive Protein Mediates Protection from Lipopolysaccharide Through Interactions With FcγR1 , 2002, The Journal of Immunology.

[44]  K. Coggeshall,et al.  C-Reactive Protein Induces Signaling Through FcγRIIa on HL-60 Granulocytes1 2 , 2002, The Journal of Immunology.

[45]  S. Tridandapani,et al.  RIIa on HL-60 Granulocytes g Through Fc C-Reactive Protein Induces Signaling , 2002 .

[46]  P. Ridker,et al.  Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. , 2002, Atherosclerosis.

[47]  C. Mold,et al.  Serum Amyloid P Component and C-Reactive Protein Opsonize Apoptotic Cells for Phagocytosis through Fcγ Receptors , 2002 .

[48]  C. Mold,et al.  Protection from Streptococcus pneumoniae Infection by C-Reactive Protein and Natural Antibody Requires Complement But Not Fcγ Receptors1 , 2002, The Journal of Immunology.

[49]  Janet M. Allen,et al.  C‐reactive protein‐mediated phagocytosis and phospholipase D signalling through the high‐affinity receptor for immunoglobulin G (FcγRI) , 2002 .

[50]  G. Cooper,et al.  Association between baseline levels of C-reactive protein (CRP) and a dinucleotide repeat polymorphism in the intron of the CRP gene , 2002, Genes and Immunity.

[51]  J. Raynes,et al.  C‐reactive protein‐mediated phagocytosis of Leishmania donovani promastigotes does not alter parasite survival or macrophage responses , 2002, Parasite immunology.

[52]  S. Humphries,et al.  Human CRP Gene Polymorphism Influences CRP Levels: Implications for the Prediction and Pathogenesis of Coronary Heart Disease , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[53]  C. Visser,et al.  C-reactive protein activates complement in infarcted human myocardium. , 2003, The American journal of pathology.

[54]  A. Agrawal,et al.  Transcription factor c-Rel enhances C-reactive protein expression by facilitating the binding of C/EBPbeta to the promoter. , 2003, Molecular immunology.

[55]  Christine Gaboriaud,et al.  The Crystal Structure of the Globular Head of Complement Protein C1q Provides a Basis for Its Versatile Recognition Properties* , 2003, Journal of Biological Chemistry.

[56]  J. Kearney,et al.  Delayed lupus onset in (NZB x NZW)F1 mice expressing a human C-reactive protein transgene. , 2003, Arthritis and rheumatism.

[57]  N. Brot,et al.  Opsonization of Apoptotic Cells and Its Effect on Macrophage and T Cell Immune Responses , 2003, Annals of the New York Academy of Sciences.

[58]  P. Ridker.  Clinical application of C-reactive protein for cardiovascular disease detection and prevention. , 2003, Circulation.

[59]  A. Agrawal,et al.  Overexpressed nuclear factor‐κB can participate in endogenous C‐reactive protein induction, and enhances the effects of C/EBPβ and signal transducer and activator of transcription‐3 , 2003, Immunology.

[60]  H. Groux,et al.  The complex role of interleukin-10 in autoimmunity. , 2003, Journal of autoimmunity.

[61]  V. Hombach,et al.  Ultrasensitive Confocal Fluorescence Microscopy of C-Reactive Protein Interacting With Fc&ggr;RIIa , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[62]  J. Whittaker,et al.  Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. , 2003, Human molecular genetics.

[63]  J. Swanson,et al.  The coordination of signaling during Fc receptor‐mediated phagocytosis , 2004, Journal of leukocyte biology.

[64]  C. Mold,et al.  C-reactive protein , 2004, Immunologic research.

[65]  J. Raynes,et al.  FcgammaRIIa expression with FcgammaRI results in C-reactive protein- and IgG-mediated phagocytosis. , 2004, Journal of leukocyte biology.

[66]  S. Devaraj,et al.  Effect of C-reactive protein on chemokine expression in human aortic endothelial cells. , 2004, Journal of molecular and cellular cardiology.

[67]  J. Raynes,et al.  FcγRIIa expression with FcγRI results in C‐reactive protein‐ and IgG‐mediated phagocytosis , 2004 .

[68]  Yan Huang,et al.  C-Reactive Protein Stimulates MMP-1 Expression in U937 Histiocytes Through Fc&ggr;RII and Extracellular Signal-Regulated Kinase Pathway:: An Implication of CRP Involvement in Plaque Destabilization , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[69]  Prapat Suriyaphol,et al.  Possible Protective Role for C-Reactive Protein in Atherogenesis: Complement Activation by Modified Lipoproteins Halts Before Detrimental Terminal Sequence , 2004, Circulation.

[70]  J. L. Ding,et al.  C-reactive protein: a predominant LPS-binding acute phase protein responsive to Pseudomonas infection , 2004, Journal of endotoxin research.

[71]  S. Nagata,et al.  Autoimmune Disease and Impaired Uptake of Apoptotic Cells in MFG-E8-Deficient Mice , 2004, Science.

[72]  L. Marnell,et al.  Reversal of ongoing proteinuria in autoimmune mice by treatment with C-reactive protein. , 2005, Arthritis and rheumatism.

[73]  J. Reveille,et al.  Systemic lupus erythematosus in a multiethnic US Cohort (LUMINA). XXX: association between C-reactive protein (CRP) gene polymorphisms and vascular events. , 2005, Rheumatology.

[74]  Xia Ding,et al.  Effect of C-reactive protein on gene expression in vascular endothelial cells , 2005 .

[75]  N. Cook,et al.  Relation of polymorphism within the C-reactive protein gene and plasma CRP levels. , 2005, Atherosclerosis.

[76]  L. Marnell,et al.  Analysis of Binding Sites in Human C-reactive Protein for FcγRI, FcγRIIA, and C1q by Site-directed Mutagenesis* , 2005, Journal of Biological Chemistry.

[77]  T. Lehtimäki,et al.  Epistatic effect of C‐reactive protein (CRP) single nucleotide polymorphism (SNP) +1059 and interleukin‐1B SNP +3954 on CRP concentration in healthy male blood donors , 2005, International journal of immunogenetics.

[78]  Xia Ding,et al.  Effect of C-reactive protein on gene expression in vascular endothelial cells. , 2005, American journal of physiology. Heart and circulatory physiology.

[79]  D. Allison,et al.  Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level , 2005, Journal of Molecular Medicine.